A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
Goff DC; Lamberti JS; Leon AC; Green MF; Miller AL; Patel J; Manschreck T; Freudenreich O; Johnson SA; Neuropsychopharmacology: Official Publication Of The American College Of Neuropsychopharmacology, 2008, vol. 33, issue 3, p 465, ISSN 0893133x. ISBN 0893133x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef